← FDA DRUG APPROVALS

FDA NDA · NDA050532

ERYTHROMYCIN

Sponsor: LILLY

APPLICATION
NDA050532
TYPE
NDA
ORIGINAL APPROVAL
1980-06-03
LATEST ACTION
1990-12-07
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

ERYTHROMYCINDiscontinued
ERYTHROMYCIN 2% · SOLUTION · TOPICAL

Approval history

1990-12-07Labeling · Supplement 5AP
1990-12-07Labeling · Supplement 6AP
1981-06-03Labeling · Supplement 10AP
1980-11-14Labeling · Supplement 9AP
1980-06-03Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →